ARTICLE | Clinical News
Intranasal morphine: Began Phase II trial
October 15, 2001 7:00 AM UTC
Nastech Pharmaceutical Co. Inc. (NSTK), Hauppauge, N.Y. Product: Intranasal morphine Business: Neurological Therapeutic category: Analgesic, Receptor agonist Target: Mu opioid receptors Description: N...